Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Daclizumab reverses intrathecal immune cell abnormalities in multiple sclerosis.
Clinical effects of natalizumab on multiple sclerosis appear early in treatment course.
PEGylated interferon beta-1a in the treatment of multiple sclerosis - an update.
Microbial colonization influences early B-lineage development in the gut lamina propria.
CHMP recommends granting a marketing authorization for Santhera's Raxone® for the treatment of Leber's Hereditary Optic Neuropathy (LHON)
Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial.
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010.
Identification of protein networks involved in the disease course of experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis.
Predicting autoimmunity after alemtuzumab treatment of multiple sclerosis.
Assessment of confirmed urinary tract infection in patients treated with dalfampridine for multiple sclerosis.
Lessons from Jack Griffin and the "pathogenesis of peripheral nerve disease".
No Regional Gray Matter Atrophy Differences between Pediatric- and Adult-Onset Relapsing-Remitting Multiple Sclerosis.
Treating multiple sclerosis with monoclonal antibodies: a 2013 update.
Fingolimod reduces recurrence of disease activity after natalizumab withdrawal in multiple sclerosis.
Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor.
Cognitive impairment as unusual first manifestation in late-onset relapsing-remitting multiple sclerosis.
Immunohistochemical detection of sphingosine-1-phosphate and sphingosine kinase-1 in human tissue samples.
The risk of multiple sclerosis in bereaved parents: A nationwide cohort study in Denmark.
Central motor conduction time may predict response to fampridine in patients with multiple sclerosis.
Slowing of brain atrophy and reductions in new multiple sclerosis lesions sustained at three years in patients treated with Genzyme's LemtradaTM
Effects of exercise in experimental autoimmune encephalomyelitis (an animal model of multiple sclerosis).
Partnering to increase access to community exercise programs for people with stroke, acquired brain injury, and multiple sclerosis.
Management of children with multiple sclerosis.
Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects.
Sodium accumulation is associated with disability and a progressive course in multiple sclerosis.

Pages